Anthropometry (1)
- WEIGHT - Subject's weight (phv00531355.v1.p1)
Demographics (2)
- AGE - Subject age at enrollment (phv00531354.v1.p1)
- SEX - Biological sex (phv00531348.v1.p1)
Disease Events (1)
- TUMOR_DIAGNOSIS - Primary cancer diagnosis (phv00531360.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00531353.v1.p1)
Other (11)
- AFFECTION_STATUS - Case control status of the subject for ibrutinib-related cardiovascular side effects (CVSEs) (phv00531352.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00531358.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00531357.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00531347.v1.p1)
- IS_TUMOR - Tumor status (phv00531359.v1.p1)
- SAMPLE_ID - Sample ID (phv00531356.v1.p1)
- SAMPLE_ID - Sample ID (phv00531350.v1.p1)
- SUBJECT_ID - Subject ID (phv00531351.v1.p1)
- SUBJECT_ID - Subject ID (phv00531346.v1.p1)
- SUBJECT_ID - Subject ID (phv00531349.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00531361.v1.p1)